GSEP
RMD icon

Golden State Equity Partners’s ResMed RMD Stock Holding History

Golden State Equity Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.7K Buy
+61
New +$15.2K ﹤0.01% 1210
2024
Q4 		– Sell
-22
Closed -$5.37K – 772
2024
Q3 		$5.37K Buy
+22
New +$4.92K ﹤0.01% 649

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Golden State Equity Partners's RMD Position: Q1 2026 in Review

Golden State Equity Partners opened a new position in ResMed (RMD) in Q1 2026: 61 shares worth $13.7K. The stake represents ﹤0.01% of the portfolio and ranks #1210 among its holdings. This is a return to the name: Golden State Equity Partners previously reported a position in RMD as recently as Q3 2024.

Golden State Equity Partners first reported a position in RMD in Q3 2024 and has held it in 2 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Golden State Equity Partners held 61 shares of ResMed worth $13.7K as of Q1 2026.
  • ResMed was a new Golden State Equity Partners position in Q1 2026.
  • ResMed made up ﹤0.01% of Golden State Equity Partners's portfolio in Q1 2026, its #1210 holding.
  • Golden State Equity Partners first reported a position in ResMed in Q3 2024 and has held it in 2 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Golden State Equity Partners's 13F filing for Q1 2026, filed 28 Apr 2026.